Deep Dives, AI, Drug Development, Drug Discovery.
to the need for a combination of potency, selectivity, and overall drug-like properties. To design a novel candidate that overcame these issues, Exscientia said it utilized its end-to-end platform to drive the discovery process, including AI-driven design, structural biology, chemistry, and